Can You Drink Alcohol While Taking CBD?

Combining CBD and alcohol is unlikely to be dangerous for most healthy adults at the doses found in typical consumer products, but the two substances do interact, and the research picture is more complex than a simple green or red light. A handful of human studies have directly tested the combination, finding mostly subtle effects on blood alcohol levels and no major safety alarms at moderate doses. At the same time, both CBD and alcohol pass through the liver, and preclinical research paints a surprisingly nuanced picture of how they influence each other’s effects on the brain and body.

Does CBD Change How Drunk You Get?

The most basic question people have is whether taking CBD alongside a drink will make them more or less intoxicated. Researchers have tested this directly, and the results are mixed but lean toward “not much changes.” A well-known 1979 study gave participants either alcohol alone or alcohol combined with CBD and found that the combination produced significantly lower blood alcohol levels than alcohol alone. Despite that, the participants in both groups showed similar levels of motor impairment, and their subjective sense of being drunk was about the same.¹ A separate study from the same year, however, found that giving CBD before alcohol did not significantly change blood alcohol levels at all.²

More recent work has largely confirmed that the interaction is minimal in practical terms. A 2023 study tested oral CBD at both 30 mg and 200 mg before a standard drink and found that while 200 mg of CBD slowed the rate at which breath alcohol levels declined, the actual magnitude of this difference was trivially small.³ A Phase I safety trial in healthy adults tested 50 mg and 100 mg of CBD alongside alcohol dosed to bring blood alcohol to roughly 0.06 percent. Neither CBD dose changed peak breath alcohol levels, the time course of alcohol in the body, or how impaired the participants felt, and there was no evidence of additional impairment four hours after dosing.⁴

The takeaway from the human data so far is that moderate CBD doses alongside moderate alcohol are not going to dramatically alter your blood alcohol level or make you noticeably more intoxicated. But the research is still thin. Most of these studies were small, short-term, and tested only a single drinking occasion with controlled doses. Nobody has studied, say, nightly CBD use combined with regular moderate drinking over weeks or months.

The Liver Question

Both CBD and alcohol are processed in the liver, which raises a reasonable concern: could combining them overburden the organ? The answer depends heavily on how much CBD you are taking.

High-dose CBD carries a documented risk of liver enzyme elevations, particularly in the context of prescription CBD used for epilepsy. A narrative review of CBD-associated liver injury found that more than three-quarters of liver enzyme elevations and nearly nine out of ten cases of drug-induced liver injury occurred in people taking oral CBD doses above 1,000 mg per day. The risk also jumped substantially in patients simultaneously taking the anti-epileptic drug valproate.⁵ Those are pharmaceutical doses far beyond what most people take from a store-bought CBD product, which typically contains 10 to 50 mg per serving. Still, adding alcohol into the mix means the liver is handling two compounds that both require metabolic work, and anyone with an existing liver condition or heavy drinking habits should treat that overlap with caution.

Interestingly, the preclinical literature tells a different story at the other end of the spectrum. In mice, CBD actually protected the liver from fatty changes caused by binge-level alcohol exposure. The mechanism appeared to involve reducing oxidative stress, blocking a key inflammatory signaling pathway, and boosting a cellular cleanup process called autophagy.⁶ These results have not been replicated in humans, and animal models of binge drinking do not perfectly mirror casual social drinking. But they hint at a paradox that runs through the CBD-alcohol research: at low to moderate doses, CBD may cushion some of the damage alcohol inflicts, while at very high doses it creates its own liver risks.

Could CBD Protect the Brain From Alcohol Damage?

Some of the most striking research on CBD and alcohol has nothing to do with getting drunk on a Friday night. It concerns whether CBD can limit the neurological harm that chronic or heavy alcohol use causes over time. This is almost entirely animal research, but the findings have been consistent enough to attract serious scientific interest.

In a rat model of binge alcohol exposure, CBD acted as a neuroprotective antioxidant, reducing markers of brain-cell death and inflammation in regions associated with decision-making and reward processing.⁷ A 2025 study in alcohol-dependent rats went further, showing that chronic CBD administration prevented neurodegeneration and neuroinflammation in specific brain areas, including parts of the striatum involved in motivation and habit formation. CBD reduced markers of cell death and inflammation while preserving neuron counts in those regions.⁸

Even early-life alcohol exposure, which models the kind of damage seen in fetal alcohol spectrum disorders, showed some responsiveness to CBD. In mice exposed to alcohol early in development, CBD treatment during a later stage of growth improved cognitive deficits and reduced elevated levels of inflammatory molecules in the hippocampus, a brain area critical for memory.⁹

None of this means you should take CBD as a brain shield while drinking. These studies used carefully controlled doses in animals, and translating rodent findings to humans is always uncertain. But the consistency of the neuroprotective signal across multiple research groups and models is part of what has driven interest in CBD as a potential therapeutic tool for alcohol-related harm, rather than just something people happen to use alongside a cocktail.

CBD and Alcohol Cravings

Perhaps the most clinically promising line of research involves CBD’s potential to reduce the urge to drink. This is where the science has started to move from animal models into human trials.

A double-blind, randomized controlled trial called the ICONIC study tested whether a single dose of CBD could dampen alcohol craving in people diagnosed with alcohol use disorder. Participants were exposed to both stress and alcohol-related cues designed to trigger the desire to drink. Those who received a placebo reported a much larger spike in craving compared to those given CBD. During a brain-imaging task, the placebo group also showed significantly higher craving when viewing alcohol-related images.¹⁰ This was a small trial and a single dose, but the effect sizes were large enough to draw attention.

Preclinical research supports this direction. A systematic review of animal studies found that CBD reduced cue-triggered and stress-triggered alcohol seeking, voluntary alcohol consumption, and impulsive behavior associated with problematic drinking patterns.¹¹ To be clear, this research positions CBD as a possible therapeutic for people struggling with alcohol dependence, not as something casual drinkers should mix with their wine. The doses used in clinical studies are typically far above what consumer products deliver, and the goal is medical treatment, not recreational pairing.

Withdrawal and Anxiety Relief in Animal Models

Related to the craving research, several animal studies have explored whether CBD eases the physical and psychological symptoms of alcohol withdrawal, a condition that can range from uncomfortable to medically dangerous. The results have been encouraging, though they remain confined to the lab.

In an alcohol-dependent rat model, CBD reduced voluntary alcohol intake during acute withdrawal, lowered the motivation to work for access to alcohol, and eased physical withdrawal symptoms like tremors and limb stiffness. The same animals showed less anxiety-like behavior during withdrawal and reduced sensitivity to pain, two common and distressing features of alcohol withdrawal in humans.⁸ Separately, a mouse study of spontaneous alcohol withdrawal found that CBD normalized anxiety-like behaviors and physical withdrawal signs in a dose-dependent fashion, with higher doses producing stronger effects. CBD also modulated gene expression changes in the brain’s reward circuitry triggered by withdrawal.¹²

These findings are not ready for clinical application. Alcohol withdrawal can be life-threatening, and no one should substitute CBD for medical supervision during detox. But the research has built enough of a case that clinical trials are now underway or being planned to test whether CBD can serve as an adjunct to existing withdrawal treatments. The appeal is partly that CBD appears to lack the abuse potential and heavy side-effect profile of many current medications used in this space.

Why Dose and Product Type Matter More Than You Think

One of the biggest gaps in this entire conversation is the difference between the CBD used in research and the CBD sold at gas stations and wellness shops. The Phase I safety trial that found no concerning interactions used pharmaceutical-grade CBD at 50 and 100 mg alongside a controlled alcohol dose.⁴ The neuroprotection studies in animals used doses scaled to body weight under laboratory conditions. Prescription CBD for epilepsy can reach 20 mg per kilogram of body weight per day, which for an average adult works out to well over a thousand milligrams.

Consumer CBD products, by contrast, are loosely regulated and wildly inconsistent. Independent testing has repeatedly found that many products contain significantly more or less CBD than their labels claim, and some contain undisclosed THC or other contaminants. A 25 mg CBD gummy from one brand is not necessarily the same experience as a 25 mg gummy from another. When you add alcohol to that uncertainty, you are combining an uncontrolled variable with a well-understood depressant.

Full-spectrum CBD products deserve special mention because they contain small amounts of THC alongside CBD. While the THC content is legally capped at 0.3 percent in most jurisdictions, even trace amounts of THC interact with alcohol differently than CBD does. THC and alcohol together are known to amplify impairment in ways CBD alone does not appear to. If your CBD product contains THC and you are drinking, the relevant research is no longer just the CBD-alcohol literature but the broader and more concerning cannabis-alcohol interaction data.

CBD-Infused Alcoholic Beverages

A small but growing market of CBD-infused beers, wines, and spirits has emerged, and these products raise their own set of questions. Regulations vary dramatically by state and country. Some jurisdictions prohibit adding CBD to alcoholic beverages entirely, while others allow it with restrictions. The U.S. Food and Drug Administration has not approved CBD as a food additive, which technically puts these products in a legal gray area regardless of state-level rules.

From a pharmacological standpoint, CBD-infused drinks introduce both substances simultaneously, which means they hit the digestive system together and compete for some of the same liver enzymes from the start. The doses of CBD in these beverages are typically low, often in the 5 to 20 mg range, which falls well below the thresholds associated with liver enzyme elevations or meaningful blood alcohol changes in the studies discussed above.⁵ Whether such low doses produce any noticeable effect beyond placebo is an open question. Most of the research showing CBD’s more interesting effects on the brain and liver used doses ten to a hundred times higher. A CBD cocktail might make for good marketing, but the science behind any claimed benefit at those doses is thin to nonexistent.

The more practical concern with these products is that consumers may not realize they are combining two active substances and may drink more freely than they would with a standard alcoholic beverage, assuming the CBD somehow offsets the alcohol. Nothing in the human data supports that assumption. The impairment from alcohol is not meaningfully blunted by CBD at any dose tested so far, and treating a CBD-infused drink as safer than a regular one could lead to riskier choices around driving or other tasks that require full coordination.

Who Should Be Especially Careful

While the combination appears relatively benign for healthy adults at typical consumer doses, some groups should be more cautious than others:

• People on medications metabolized by the liver: CBD inhibits certain liver enzymes that process a wide range of drugs, from blood thinners to antidepressants. Adding alcohol to the mix creates a three-way competition for metabolic resources, which can raise blood levels of the medication unpredictably.¹³
• People with liver disease: Even if animal research suggests CBD has hepatoprotective properties, those findings involve controlled doses in otherwise-healthy animals. A compromised liver is less equipped to handle any additional metabolic load, and combining CBD with alcohol in that context is a gamble without clinical data to guide it.
• Heavy drinkers: The neuroprotection and liver-protection findings from animal studies are intriguing, but they do not constitute a green light to use CBD as damage control for excessive drinking. The protective doses and the real-world scenario of chronic heavy use are entirely different situations.
• People taking high-dose CBD for epilepsy: Prescription CBD at 1,000 mg or more per day already carries a meaningful risk of liver enzyme elevations. Adding alcohol on top of those doses, especially regularly, increases the metabolic strain on the liver substantially.⁵

For the average person taking 25 to 50 mg of CBD from a reputable product and having a drink or two, the existing human evidence does not point to a significant safety concern. But “existing evidence” is doing heavy lifting in that sentence. The research base is small, short-term, and concentrated at specific doses. The honest answer is that occasional, moderate use of both substances is probably fine for most healthy adults, while the long-term picture and the interaction at higher doses remain genuinely unknown.